Forecast of actin-binding proteins as the oncotarget in osteosarcoma - a review of mechanism, diagnosis and therapy
Osteosarcoma (OS) is the most common bone malignant tumor with a high rate of lung metastasis and principally emerges in children and adolescents. Although neoadjuvant chemotherapy is widely used around the world, a high rate of chemoresistance occurs and frequently generates a poor prognosis. Therefore, finding a new appropriate prognostic marker for OS is a valuable research direction, which will give patients a better chance to receive proper therapy. Actin-binding proteins (ABPs) are a group of proteins that interact with actin cytoskeleton and play a crucial role in the regulation of the cell motility and morphology in eukaryotes. Meanwhile, ABPs also act as a bridge between the cytomembrane and nucleus, which transmit the outside-in and inside-out signals in cytoplasm. Furthermore, ABPs alter the dynamic structure of actin and regulate the invasion and metastasis of cancer. Hence, ABPs have a wide application in predicting the prognosis, and may be new targets, in tumor therapy. This review focuses on a series of ABPs and discusses their modulatory functions. It provides a new insight into the classification of ABPs' functions in the process of invasion and metastasis in OS and illuminates the potential ability in predicting the prognosis of OS patients.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2018 |
---|---|
Erschienen: |
2018 |
Enthalten in: |
Zur Gesamtaufnahme - volume:11 |
---|---|
Enthalten in: |
OncoTargets and therapy - 11(2018) vom: 01., Seite 1553-1561 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Fu, Yucheng [VerfasserIn] |
---|
Links: |
---|
Themen: |
Actin-binding proteins |
---|
Anmerkungen: |
Date Revised 30.09.2020 published: Electronic-eCollection Citation Status PubMed-not-MEDLINE |
---|
doi: |
10.2147/OTT.S159894 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM282444637 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM282444637 | ||
003 | DE-627 | ||
005 | 20231225033934.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2018 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.2147/OTT.S159894 |2 doi | |
028 | 5 | 2 | |a pubmed24n0941.xml |
035 | |a (DE-627)NLM282444637 | ||
035 | |a (NLM)29593421 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Fu, Yucheng |e verfasserin |4 aut | |
245 | 1 | 0 | |a Forecast of actin-binding proteins as the oncotarget in osteosarcoma - a review of mechanism, diagnosis and therapy |
264 | 1 | |c 2018 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 30.09.2020 | ||
500 | |a published: Electronic-eCollection | ||
500 | |a Citation Status PubMed-not-MEDLINE | ||
520 | |a Osteosarcoma (OS) is the most common bone malignant tumor with a high rate of lung metastasis and principally emerges in children and adolescents. Although neoadjuvant chemotherapy is widely used around the world, a high rate of chemoresistance occurs and frequently generates a poor prognosis. Therefore, finding a new appropriate prognostic marker for OS is a valuable research direction, which will give patients a better chance to receive proper therapy. Actin-binding proteins (ABPs) are a group of proteins that interact with actin cytoskeleton and play a crucial role in the regulation of the cell motility and morphology in eukaryotes. Meanwhile, ABPs also act as a bridge between the cytomembrane and nucleus, which transmit the outside-in and inside-out signals in cytoplasm. Furthermore, ABPs alter the dynamic structure of actin and regulate the invasion and metastasis of cancer. Hence, ABPs have a wide application in predicting the prognosis, and may be new targets, in tumor therapy. This review focuses on a series of ABPs and discusses their modulatory functions. It provides a new insight into the classification of ABPs' functions in the process of invasion and metastasis in OS and illuminates the potential ability in predicting the prognosis of OS patients | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Review | |
650 | 4 | |a actin-binding proteins | |
650 | 4 | |a oncotarget | |
650 | 4 | |a oncotherapy | |
650 | 4 | |a osteosarcoma | |
650 | 4 | |a tumor invasion and metastasis | |
700 | 1 | |a Yu, Wei |e verfasserin |4 aut | |
700 | 1 | |a Cai, Hongliu |e verfasserin |4 aut | |
700 | 1 | |a Lu, Anwei |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t OncoTargets and therapy |d 2008 |g 11(2018) vom: 01., Seite 1553-1561 |w (DE-627)NLM199447950 |x 1178-6930 |7 nnns |
773 | 1 | 8 | |g volume:11 |g year:2018 |g day:01 |g pages:1553-1561 |
856 | 4 | 0 | |u http://dx.doi.org/10.2147/OTT.S159894 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 11 |j 2018 |b 01 |h 1553-1561 |